Corporations engaged in the manufacture and sale of valuable, often life-saving pharmaceuticals, chemicals and medical devices routinely find themselves as a target for litigation or investigations. Dentons' Pharmaceutical, Chemical and Medical Device Litigation practice is strategically positioned to effectively resolve such matters. Our capabilities and experience span across the full range of functional areas critical to the resolution of disputes for life sciences companies, including:

• Product liability litigation
• Commercial and class action litigation
• Global compliance and investigations
• State-Attorney General matters
• Securities litigation
• Competition and antitrust litigation
• Intellectual property litigation
• Employment litigation
• Tax disputes and controversies

To enhance our litigation and investigation services, we also draw on the experience and skill of our health care, public policy and regulatory lawyers, and we routinely liaise with our colleagues located throughout the world. Indeed, our unparalleled global capabilities as the world’s largest law firm provides us with a distinct advantage in confronting legal and compliance issues on a global scale.

Our dispute resolution team has secured victories and achieved excellent client results at all phases of the litigation life cycle. We handle individual cases, high stakes class action and complex litigation, and cross-border investigations and arbitrations. We regularly work with leading experts in the areas of biotechnology, warnings, state of the art, medicine, industrial hygiene, epidemiology, genetics, materials science and other specialties. Our lawyers are not intimidated by science, have substantial in-house knowledge and have cultivated external resources to ensure that we provide a sophisticated and smart defense to the clients we represent.        

In all matters, our guiding philosophy is to work closely with our clients to protect their market positions, reduce or eliminate risk, and position them for further growth.

Insights

How to Build a Winning Defense Case – Pretrial Strategy

February 27, 2025

Begin with the End in Mind. From the very inception of a potential high exposure case, defense counsel should begin formulating a plan for achieving victory at the end of the case, whether by motion and/or trial. When defense counsel takes this approach in a disciplined and rigorous manner, counsel optimizes the opportunity for a positive outcome.

Introduction to Dentons’ Trial Strategy Series

February 27, 2025

Over the past fifteen years, we have seen a concerning rise in "nuclear verdicts," or jury awards of $10 million or more. While this development undoubtedly benefits contingency fee plaintiffs’ lawyers, it presents significant potential adverse consequences to corporate defendants and the people they employ. This article explores the data concerning the rise in nuclear verdicts and introduces the Dentons US Trial Strategy Series.

The Causes of Excessive Jury Verdicts

February 27, 2025

Before exploring strategies to counteract the rise in escalating jury verdicts, it is essential to understand the causes of such outcomes. This article delves into the causes of oversized jury awards.

News and Events

Recent Press Releases

Dentons publishes Global Litigation and Dispute Resolution Q&A Guide

June 20, 2017

Dentons has published its first-ever Global Litigation and Dispute Resolution Q&A Guide, which offers the current view on dispute resolution in 27 jurisdictions across the globe.